Carlsmed Inc (CARL)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1068)

858-295-9290

1800 ASTON AVENUE, CARLSBAD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CARL's Discussions on Twitter

Compare CARL vs VEEV, TEM, BTSG, TXG, HNGE

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CARL Carlsmed Inc	14.82	404.63M	56.44M	-32.60M	-35.15M	-1.2318
VEEV Veeva Systems Inc	274.84	44.50B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	82.24	14.93B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	56.02	11.08B	13.65B	169.86M	412.12M	1.0758
TXG 10 X Genomics Inc	84.11	10.96B	638.78M	-22.66M	122.18M	-0.1744
HNGE Hinge Health Inc	91.98	7.42B	646.34M	-512.40M	202.76M	-6.6871

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-18	Eingeleitet	BTIG Research	Buy
2025-08-18	Eingeleitet	BofA Securities	Buy
2025-08-18	Eingeleitet	Goldman	Buy
2025-08-18	Eingeleitet	Piper Sandler	Overweight
2025-08-18	Eingeleitet	Truist	Buy

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Carlsmed Inc-Aktie (CARL) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Cordonnier Michael	CEO, President	Mar 02 '26	Option Exercise	0.34	197,855	66,281	1,554,501
Cordonnier Michael	CEO, President	Mar 02 '26	Sale	13.29	197,855	2,629,889	1,356,646

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Compare CARL vs VEEV, TEM, BTSG, TXG, HNGE

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Carlsmed, Inc.(NasdaqGS: CARL) added to S&P Global BMI Index - marketscreener.com

Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com Nigeria

Presidio Management Group XII buys $3m in Carlsmed stock - Investing.com

Carlsmed files patent lawsuit against DeGen Medical By Investing.com - Investing.com Australia

Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical - manilatimes.net

Carlsmed files patent lawsuit against DeGen Medical - Investing.com

Carlsmed Files Patent Infringement Lawsuit Against DeGen Medical Over Spine Surgery Technologies - quiverquant.com

Ten percent owner boosts stake in Carlsmed (CARL) - Stock Titan

Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Carlsmed COO Jeffrey Bertolini Awarded 50,000 Stock Options with $15.23 Exercise Price - Kalkine Media

Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan

Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan

Carlsmed, Inc. Announces Chief Operating Officer Appointment - The Manila Times

Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com

Carlsmed appoints Jeff Bertolini as new COO - TipRanks

Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView

symbol__ Stock Quote Price and Forecast - cnn.com

BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat

Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com

Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat

Carlsmed (CARL) Earnings Snapshot: EPS Lands Above Forecast on the Day; The Stock Ends Down 1.56% in the Current UpdateEPS Surprise History - dars.gov.et

Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat

Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan

Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView

Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com

CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView

Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine

Carlsmed, Inc. (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca

Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa

Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks

Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - The Globe and Mail

Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer

Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria

CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo

Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating - marketscreener.com

Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView

Carlsmed Inc. (CARL) Advances 4.79% to $14.21: Personalized Spine Tech Gains TractionHigh Reward Trades - dars.gov.et

Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ... - Yahoo Finance UK

Carlsmed Q2 Earnings Call Highlights - Yahoo Finance

Carlsmed, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

CARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary - TradingView

Carlsmed reports Q2 2026 revenue $18.9M, raises full-year guidance to $74–$78M - TradingView

Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance - The Manila Times

Carlsmed, Inc. Raises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com

Carlsmed, Inc. $CARL Stock Holdings Lifted by Janus Henderson Group PLC - MarketBeat

Carlsmed (CARL) Earnings Date and Reports 2026 $CARL - MarketBeat

Carlsmed (CARL) Gains Favorable CMS Reimbursement Policy Boostin - GuruFocus

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Carlsmed Inc-Aktie (CARL) Insiderhandel

Ähnlich wie CARL